logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
S

Sun Young Rha

Yonsei University

86H-index
1.3KPaper Count
3.5WCitation Count
Published Papers 361
Publication Date
logo
Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
errNature
IF48.5
err2026-08-04
err0
errOAAI
errToni K. Choueiri; Jaime Merchán; Amita Patnaik; Alexandra Drakaki; Brian I. Rini; Sun Young Rha; Jae Lyun Lee; Moshe C. Ornstein; Rohit Kumar; Clara Hwang; Yusra Shao; Se Hoon Park; Pedro C. Barata; Bradley A. McGregor; Paul Foster; Jianfen Chen; Melissa Eisen; Hunter Cole; Ben Weeder; Yinghui Guan; Jaskirat Singh; Angelo Kaplan; Soonweng Cho; Richard Markus; Omar Kabbarah; Rana R. McKay
errShare
errSave
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
errNature
IF48.5
err2026-07-01
err0
errOAAI
errToni K. Choueiri; Jamie Merchan; Amita Patnaik; Alexandra Drakaki; Brian I. Rini; Sun Young Rha; Jae Lyun Lee; Moshe C. Ornstein; Rohit Kumar; Clara Hwang; Yusra Shao; Se Hoon Park; Pedro C. Barata; Bradley A. McGregor; Paul Foster; Jianfen Chen; Melissa Eisen; Hunter Cole; Ben Weeder; Yinghui Guan; Jaskirat Singh; Angelo Kaplan; Soonweng Cho; Richard Markus; Omar Kabbarah; Rana R. McKay
errShare
errSave
Clinicopathologic characteristics and genomic profiling of HER2-low advanced gastric or gastroesophageal junction cancer
errESMO Open
IF8.3
err2026-05-13
err0
errOAAI
errC.K. Lee; D.H. Seo; S. Park; T. Yuh; Y. Kim; H. Park; J.S. Shim; H. Kim; H.S. Kim; M. Jung; H.C. Chung; S.Y. Rha
errShare
errSave
Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer
errJournal of Gastric Cancer
IF3.8
err2026-04-01
err1
PREAI
errMoon, Ye Jin; Kwon, Woo Sun; Park, Chan Hee; Jang, Jinsoo; Park, Juin; Yoon, Byeong Gyu; Mun, Han Byeol; Kim, Namju; Lee, Choong-kun; Jeung, Hei Cheul; Shin, Su-Jin; Kim, Tae Soo; Rha, Sun Young
errShare
errSave
Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
errCancer Research Communications
IF0
err2026-03-01
err2
PREAI
errPonz-Sarvise, Mariano; Rha, Sun Young; Gomez-Roca, Carlos A.; Ortega Moran, Laura; Gill, Sanjeev; Tortora, Giampaolo; Geva, Ravit; Saada-Bouzid, Esma; Santoro, Armando; Kim, Tae Won; Heudobler, Daniel; Dutcus, Corina E.; Okpara, Chinyere E.; Ghori, Razi; Zhang, Yiwei; Vajdi, Amir; Dettman, E. J.; Jin, Fan; Groisberg, Roman; Shapira-Frommer, Ronnie
errShare
errSave
From Control to Conversion: Optimizing Systemic Therapy for Curative-Intent Conversion Surgery in Metastatic Gastric Cancer
errJournal of Gastric Cancer
IF3.8
err2026-01-01
err0
PREAI
errHan, Hye Sook; Rha, Sun Young
errShare
errSave
Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial
errNature Medicine
IF50
err2025-10-18
err0
errOAAI
errYelena Y. Janjigian; Do-Youn Oh; Meredith Pelster; Zev A. Wainberg; Subhransu Prusty; Sandahl Nelson; Amy DuPage; Amy Thompson; Daniel O. Koralek; Edward Allan R. Sison; Sun Young Rha
errShare
errSave
Combination casdatifan plus cabozantinib in previously treated patients with clear cell renal cell carcinoma: results from an expansion cohort of ARC-20 (NCT05536141)
errONCOLOGIST
IF4.2
err2025-10-01
err0
errOAAI
errChoueri, Toni; Ornstein, Moshe; Barata, Pedro C.; Matrana, Marc; Merchan, Jaime; Gedye, Craig; Hwang, Clara; Kumar, Rohit; Lee, Jae Lyun; Guan, Yinghui; Ghasemi, Mohammad; Quadri, Syed; Negro, Chris; Chen, Jianfen; Foster, Paul; Warad, Deepti; McGregor, Bradley A.; Rha, Sun Young; Drakaki, Alexandra
errShare
errSave
Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial
errESMO Open
IF8.3
err2025-09-30
err0
errOAAI
errY.Y. Janjigian; A. Kawazoe; J. Xu; S. Lonardi; J.-P. Metges; L.S. Wyrwicz; L. Shen; Y. Ostapenko; M. Bilici; M.A. Lowery; A. Valderrama; Y. Guan; K. Li; C.-S. Shih; S.Y. Rha
errShare
errSave
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial
errEuropean Journal of Cancer
IF7.1
err2025-09-20
err0
PREAI
errMaeve A. Lowery; Lucjan S. Wyrwicz; Do-Youn Oh; Kai-Keen Shiu; Patricio Yañez; Yuxian Bai; Min-Hee Ryu; Jeeyun Lee; Fernando Rivera; Gustavo Vasconcelos Alves; Marcelo Garrido; Manuel González Fernández; Jin Li; Timuçin Çil; Felipe Melo Cruz; Shukui Qin; Yanfen Guan; Adriana Valderrama; Sonal Bordia; Sun Young Rha
errShare
errSave
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort
errCancer
IF5.1
err2025-08-13
err0
errOAAI
errSun Young Rha MD, PhD; Eduardo Castanon MD; Sanjeev Gill MBBS, FRACP; Helene Senellart MD; Juanita Lopez MD, PhD; Iván Márquez-Rodas MD, PhD; Iván Victoria MD; Tae Min Kim MD, PhD; Zarnie Lwin MBBS, FCP, FRACP; Michael C. Burger MD; Matteo Simonelli MD; Philippe A. Cassier MD, PhD; Andrew E. Hendifar MD; Paolo A. Ascierto MD; Corina Dutcus MD; Chinyere E. Okpara PhD; Razi Ghori PhD; Fan Jin MD; Roman Groisberg MD; Luis Villanueva MD, MSc
errShare
errSave
Corrigendum to “Efficacy of the first-line immune checkpoint inhibitor plus chemotherapy for gastroesophageal cancer: A meta-analysis of phase III trials including unreported PD-L1 subgroups” [Cancer Lett. 623, (2025) 217718]
errCancer Letters
IF10.1
err2025-06-03
err0
PREAI
errLee, Choong-kun; Park, Sejung; Lee, Yaeji; Yun, Choa; Hong, Moonki; Nam, Chung Mo; Chung, Hyun Cheol; Rha, Sun Young
errShare
errSave
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
errlancet oncology
IF0
err2025-06-02
err0
PREAI
errElena Elimova; Jaffer Ajani; Howard Burris; Crystal S Denlinger; Syma Iqbal; Yoon-Koo Kang; Jwa Hoon Kim; Keun-Wook Lee; Bruce Lin; Rutika Mehta; Do-Youn Oh; Sun Young Rha; Young Mi Seol; Lin Yang; Mark A Ozog; Phillip M Garfin; Geoffrey Ku
errShare
errSave
FGFR2b protein overexpression: An emerging biomarker in gastric and gastroesophageal junction adenocarcinoma
errCancer Treatment Reviews
IF10.5
err2025-05-26
err0
errOAAI
errElizabeth C. Smyth; Kyoung-Mee Kim; Sun Young Rha; Zev A. Wainberg; Hayden Honeycutt; Erica Sommermann; Atsushi Ochiai
errShare
errSave
First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305
errADVANCES IN THERAPY
IF4
err2025-03-01
err0
errOAAI
errMoehler, Markus; Oh, Do-Youn; Kato, Ken; Arkenau, Tobias; Tabernero, Josep; Lee, Keun-Wook; Rha, Sun Young; Hirano, Hidekazu; Spigel, David; Yamaguchi, Kensei; Wyrwicz, Lucjan; Disel, Umut; Pazo-Cid, Roberto A.; Fornaro, Lorenzo; Xu, Yaling; Sheng, Tao; Yang, Silu; Kadva, Alysha; Cruz-Correa, Marcia; Xu, Rui-Hua
errShare
errSave
An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations
errESMO OPEN
IF8.3
err2025-02-01
err0
PREAI
errKim, K. H.; Park, C.; Beom, S. -H; Kim, M. H.; Kim, C. G.; Kim, H. R.; Jung, M.; Shin, S. J.; Rha, S. Y.; Kim, H. S.
errShare
errSave
Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024
errgastric cancer
IF3.8
err2025-01-01
err1
PREAI
errKim, Tae-Han; Uyama, Ichiro; Rha, Sun Young; Bencivenga, Maria; An, Jiyeong; Wyrwicz, Lucjan; Koo, Dong-Hoe; van Hillegersberg, Richard; Lee, Keun-Wook; Li, Guoxin; Yoshikawa, Takaki; Badgwell, Brian; Lorenzen, Sylvie; Kim, In-Ho; Lee, In-Seob; Han, Hye-Sook; Hoon, Hur
errShare
errSave
EDGE-Gastric Arm A1: Phase II study of domvanalimab (D), zimberelimab (Z), and FOLFOX in first-line (1L) advanced gastroesophageal (GE) cancer
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errRha, S. Y.; Oh, D-Y.; Pelster, M.; Wainberg, Z. A.; Sison, A.; Scott, J.; Nelson, S.; Wishengrad, D.; Rhee, J.; Nuyten, D. S. A.; Janjigian, Y. Y.
errShare
errSave
Real-world treatment (Tx) patterns in patients (pts) with HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (HER2+aGC/GEJC) in East Asia (HER2+GASTA)
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errOh, D-Y.; Yeo, W.; Chen, J-S.; Ba, Y.; Chan, W. W. L.; Chen, M-J.; Chen, Y. H.; Gu, K.; Hung, Y-P.; Kim, J. G.; Lee, J.; Liang, X.; Luo, S.; Rha, S. Y.; Yuan, Y.; Kim, T.; Yanagida, M.; Sato, R.; Xu, R-H.
errShare
errSave
Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err2
errOAAI
errMotzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Gruenwald, V.; George, S.; Markensohn, J.; Burgents, J. E.; Cristescu, R.; Sachdev, P.; Narita, Y.; Huang, J.; Zhao, Z.; Okpara, C. E.; Minoshima, Y.; Choueiri, T. K.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
Gordon B. Mills
H-index: 231 · Papers: 3.5K
E
Eric Van Cutsem
H-index: 174 · Papers: 1.8K
P
P. Andrew Futreal
H-index: 159 · Papers: 1.3K
J
Jean‐Yves Blay
H-index: 158 · Papers: 2.4K
J
Jaffer A. Ajani
H-index: 152 · Papers: 1.7K
View more